These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4477598)

  • 1. [Pharmacokinetics on drug interaction: effect of zoxazolamine on the plasma concentration time course of chlorzoxazone].
    Sakiya Y; Awazu S; Hanano M; Nogami H
    Yakugaku Zasshi; 1974 Oct; 94(10):1307-11. PubMed ID: 4477598
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacodynamics of zoxazolamine and chlorzoxazone in rats.
    Yasuhara M; Levy G
    Pharm Res; 1988 Jul; 5(7):401-7. PubMed ID: 3247308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatography in pharmaceutical analysis X: Determination of chlorzoxazone and hydroxy metabolite in plasma.
    Honigberg IL; Stewart JT; Coldren JW
    J Pharm Sci; 1979 Feb; 68(2):253-5. PubMed ID: 423105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the analgesic muscle relaxants chlorzoxazone and diazepam in human plasma by reversed-phase liquid chromatography.
    Gaitonde CD; Pathak PV
    J Chromatogr; 1990 Jun; 528(2):407-14. PubMed ID: 2384578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatography with electrochemical detection of chlorzoxazone and its hydroxy metabolite in serum using solid-phase extraction.
    Stewart JT; Carter HK
    J Chromatogr; 1986 Jul; 380(1):177-83. PubMed ID: 3745381
    [No Abstract]   [Full Text] [Related]  

  • 6. Kinetics of drug action in disease states. XXVII. Effect of experimental renal failure on the pharmacodynamics of zoxazolamine and chlorzoxazone.
    Yasuhara M; Levy G
    J Pharmacol Exp Ther; 1988 Jul; 246(1):165-9. PubMed ID: 3260625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of recombinant small-conductance Ca(2+)-activated K(+) channels by the muscle relaxant chlorzoxazone and structurally related compounds.
    Cao Y; Dreixler JC; Roizen JD; Roberts MT; Houamed KM
    J Pharmacol Exp Ther; 2001 Mar; 296(3):683-9. PubMed ID: 11181893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolongation of chlorzoxazone plasma levels by zoxazolamine.
    POOLE JW; GARDOCKI JF
    J Pharm Sci; 1963 May; 52():486-9. PubMed ID: 13972181
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of chlorzoxazone in humans.
    Desiraju RK; Renzi NL; Nayak RK; Ng KT
    J Pharm Sci; 1983 Sep; 72(9):991-4. PubMed ID: 6631711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of zoxazolamine and related centrally acting muscle relaxants on nigrostriatal dopaminergic neurons.
    Matthews RT; McMillen BA; Speciale SG; Jarrah H; Shore PA; Sanghera MK; Shepard PD; German DC
    Brain Res Bull; 1984 May; 12(5):479-86. PubMed ID: 6467036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorometric determination of chlorzoxazone in tablets and biological fluids.
    Stewart JT; Chan CW
    J Pharm Sci; 1979 Jul; 68(7):910-2. PubMed ID: 458615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of Cl(-) secretion by chlorzoxazone.
    Singh AK; Devor DC; Gerlach AC; Gondor M; Pilewski JM; Bridges RJ
    J Pharmacol Exp Ther; 2000 Feb; 292(2):778-87. PubMed ID: 10640318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical comparison of chlorzoxazone and zoxazolamine with special reference to use of muscle relaxants in rheumatic diseases.
    PEAK WP; SMITH RT
    Pa Med J; 1960 Jun; 63():833-7. PubMed ID: 14431209
    [No Abstract]   [Full Text] [Related]  

  • 14. Dose-dependent pharmacokinetics of zoxazolamine in the rat.
    Van der Graaff M; Vermeulen NP; Crul IE; Breimer DD
    Drug Metab Dispos; 1986; 14(3):331-5. PubMed ID: 2872034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of thymectomy on zoxazolamine paralysis and metabolism in untreated and (PCN) pregnenolone-16alpha-carbonitril- or ACTH-pretreated rats.
    Szabo S; Kourounakis P; Garg BD; Silva OM
    Arch Int Pharmacodyn Ther; 1975 Jun; 215(2):208-14. PubMed ID: 169755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical pharmacological considerations of zoxazolamine and chlorzoxazone metabolism.
    CONNEY AH; BURNS JJ
    Ann N Y Acad Sci; 1960 Mar; 86():167-77. PubMed ID: 13811546
    [No Abstract]   [Full Text] [Related]  

  • 17. Ultrasensitive quantification of the CYP2E1 probe chlorzoxazone and its main metabolite 6-hydroxychlorzoxazone in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry after chlorzoxazone microdosing.
    Witt L; Suzuki Y; Hohmann N; Mikus G; Haefeli WE; Burhenne J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():207-13. PubMed ID: 27300008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of chronic and acute 1 -tetrahydrocannabinol pretreatment with zoxazolamine and barbiturates.
    Sofia RD
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):91-8. PubMed ID: 4686112
    [No Abstract]   [Full Text] [Related]  

  • 19. [The clinical and experimental studies on the mechanism of a kind of muscle relaxant "chlorzoxazone" by use of evoked potential electromyography].
    OTSUKA K
    Kumamoto Igakkai Zasshi; 1962 Aug; 36():610-34. PubMed ID: 13940674
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms in the potentiation and inhibition of pharmacological actions of hexobarbital and zoxazolamine by glycofurol.
    Yasaka WJ; Sasame HA; Saul W; Maling HM; Gillette JR
    Biochem Pharmacol; 1978; 27(24):2851-8. PubMed ID: 736977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.